This is a Competing Renewal application for continued support of an NHLBI (Lung Division) Post-Doctoral Training Grant, which is currently in its 20th year in the Medical School, Department of Pathology at the University of Michigan.
The aim of this program is to provide in depth training in basic research to holders of MD, PhD or DVM degrees. The research areas of focus include lung inflammation (mediators and regulators), complement, apoptosis, DNA repair, immunopathology (including the roles of oxidants, proteases, cytokines, chemokines) and endothelial cell biology. Since inception, the program has been led by Professor Peter A. Ward. Currently all trainees are assigned to research laboratories in the Department of Pathology. Trainees flow smoothly between laboratories because of the close collaborative interactions between preceptors. The program features weekly research seminars and six annual and formal seminars on ethics in research. This training program has an impressive record of training MD's and PhD's, the majority of whom hold academic appointments. Over the past five years a concerted effort has been successful in recruiting trainees from under-represented racial/ethnic groups. The intellectual and scientific environment at the University of Michigan Medical center is very enriched for the trainees. The many core scientific facilities in the Medical School greatly enhance opportunities for trainees involved both in bench laboratory research and in animal research. The setting of the program in the context of a large academic medical center provides special advantages to trainees who can take advantage of the relevance of fundamental biomedical research to clinical diseases. This long established training program with a proven record of success positions the program to be very competitive and successful in recruitment of candidates for appointment as post-doctoral fellows.
| Bringman-Rodenbarger, Lauren R; Guo, Angela H; Lyssiotis, Costas A et al. (2018) Emerging Roles for SIRT5 in Metabolism and Cancer. Antioxid Redox Signal 28:677-690 |
| Habiel, David M; Espindola, Milena S; Coelho, Ana L et al. (2018) Modeling Idiopathic Pulmonary Fibrosis in Humanized Severe Combined Immunodeficient Mice. Am J Pathol 188:891-903 |
| Fattahi, Fatemeh; Frydrych, Lynn M; Bian, Guowu et al. (2018) Role of complement C5a and histones in septic cardiomyopathy. Mol Immunol 102:32-41 |
| Werner, Jessica L; Escolero, Sylvia G; Hewlett, Jeff T et al. (2017) Induction of Pulmonary Granuloma Formation by Propionibacterium acnes Is Regulated by MyD88 and Nox2. Am J Respir Cell Mol Biol 56:121-130 |
| Zeng, M Y; Inohara, N; Nuñez, G (2017) Mechanisms of inflammation-driven bacterial dysbiosis in the gut. Mucosal Immunol 10:18-26 |
| Pickard, Joseph M; Zeng, Melody Y; Caruso, Roberta et al. (2017) Gut microbiota: Role in pathogen colonization, immune responses, and inflammatory disease. Immunol Rev 279:70-89 |
| Bermick, Jennifer R; Lambrecht, Nathalie J; denDekker, Aaron D et al. (2016) Neonatal monocytes exhibit a unique histone modification landscape. Clin Epigenetics 8:99 |
| He, Yuan; Zeng, Melody Y; Yang, Dahai et al. (2016) NEK7 is an essential mediator of NLRP3 activation downstream of potassium efflux. Nature 530:354-7 |
| Habiel, David M; Krepostman, Nicolas; Lilly, Michael et al. (2016) Senescent stromal cell-induced divergence and therapeutic resistance in T cell acute lymphoblastic leukemia/lymphoma. Oncotarget 7:83514-83529 |
| Kalbitz, Miriam; Fattahi, Fatemeh; Herron, Todd J et al. (2016) Complement Destabilizes Cardiomyocyte Function In Vivo after Polymicrobial Sepsis and In Vitro. J Immunol 197:2353-61 |
Showing the most recent 10 out of 93 publications
